GenSail Biotech(Shanghai)Co., Ltd. now has a total four thousand square meters international-competitive R&D base which meets the requirements of GMP for tumor immunotherapy and gene therapy vector. Our technology and management team has more than 20 years of research and development experience in cancer, genetic diseases, and new generation vaccines. We have expertise in engineering and developing a wide range of recombinant viruses, including adenoviruses, herpes simplex virus and Vesicular Stomatitis Virus etc. We now offer viral vector design, custom cloning and production services.